Neonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary Report

Nutrients. 2017 Apr 11;9(4):375. doi: 10.3390/nu9040375.

Abstract

A low birth weight (LBW) leads to a higher risk of metabolic syndrome in adulthood. Literature suggests that citrulline supplementation in adulthood prevents the effect of a high fructose diet on energy metabolism. Whether neonatal citrulline supplementation would alter early growth or energy metabolism in the long-term in rats with LBW is unknown. LBW pups born from dams fed a low (4%) protein diet, were nursed by normally-fed dams and received isonitrogenous supplements of either l-citrulline or l-alanine by gavage from the sixth day of life until weaning, and were subsequently exposed to 10%-fructose in drinking water from weaning to 90 days of age. The oral glucose tolerance was tested (OGTT) at 70 days of age, and rats were sacrificed at 90 days of age. Pre-weaning citrulline supplementation failed to alter the growth trajectory, OGTT, plasma triglycerides, or fat mass accretion in adulthood; yet, it was associated with increased liver triglycerides, decreased liver total cholesterol, and a distinct liver lipidomic profile that may result in a predisposition to liver disease. We conclude that pre-weaning supplementation with citrulline does not impact early growth, but might impact liver fat metabolism in adulthood upon exposure to a high fructose diet.

Keywords: amino acids; developmental origins of health and disease (DOHaD); lipidomics; liver; low birth weight; metabolic syndrome.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Animals, Newborn
  • Birth Weight
  • Citrulline / adverse effects*
  • Citrulline / therapeutic use
  • Diet, Carbohydrate Loading / adverse effects
  • Diet, Protein-Restricted / adverse effects
  • Dietary Supplements* / adverse effects
  • Female
  • Fetal Growth Retardation / etiology
  • Fetal Growth Retardation / metabolism
  • Fetal Growth Retardation / physiopathology*
  • Fructose / adverse effects
  • Hepatic Insufficiency / etiology*
  • Hepatic Insufficiency / metabolism
  • Hepatic Insufficiency / physiopathology
  • Lactation
  • Lipid Metabolism*
  • Liver / metabolism*
  • Liver / physiopathology
  • Male
  • Maternal Nutritional Physiological Phenomena
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / prevention & control
  • Pilot Projects
  • Pregnancy
  • Random Allocation
  • Rats, Sprague-Dawley
  • Weaning

Substances

  • Citrulline
  • Fructose